Raphael Townshend is the Founder and CEO of Atomic AI, where he leads efforts to harness artificial intelligence for breakthroughs in RNA structure discovery and therapeutics. His work focuses on combining cutting-edge machine learning with molecular biology to accelerate scientific discovery and enable new classes of medicines. Throughout his career, Raphael has championed interdisciplinary innovation, building teams and technologies that push the boundaries of computational and structural biology. Under his leadership, Atomic AI advances platforms that help researchers understand RNA function with unprecedented precision. He is recognized for pioneering contributions at the intersection of AI and life sciences.